Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 73 to 84 of 84 entries
Sorted by: Best Match Show Resources per page
[No title available]

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz

Seifried J, Hoffmann A, Reda S, Böttcher S, Abu Sin M, Hofmann A, Noll I, von Laer A, Reuss A, Oh DY, Albrecht S, Stern D, Willrich N, Staat D, Zacher B, Schneider M, Feig M, Nitsche A, Rieck T, Rexroth U, Eckmanns T, Hamouda O.
PMID: 34387716
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Oct;64(10):1315. doi: 10.1007/s00103-021-03398-7.

No abstract available.

Cite
Seifried J, Hoffmann A, Reda S, et al. Erratum zu: Erfassung der Labortestungen auf SARS-CoV-2 in Deutschland. . Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021;64(10):1315doi: 10.1007/s00103-021-03398-7.
Seifried, J., Hoffmann, A., Reda, S., Böttcher, S., Abu Sin, M., Hofmann, A., Noll, I., von Laer, A., Reuss, A., Oh, D. Y., Albrecht, S., Stern, D., Willrich, N., Staat, D., Zacher, B., Schneider, M., Feig, M., Nitsche, A., Rieck, T., Rexroth, U., Eckmanns, T., & Hamouda, O. (2021). Erratum zu: Erfassung der Labortestungen auf SARS-CoV-2 in Deutschland. . Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 64(10), 1315. https://doi.org/10.1007/s00103-021-03398-7
Seifried, Janna, et al. "Erratum zu: Erfassung der Labortestungen auf SARS-CoV-2 in Deutschland." . Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz vol. 64,10 (2021): 1315. doi: https://doi.org/10.1007/s00103-021-03398-7
Seifried J, Hoffmann A, Reda S, Böttcher S, Abu Sin M, Hofmann A, Noll I, von Laer A, Reuss A, Oh DY, Albrecht S, Stern D, Willrich N, Staat D, Zacher B, Schneider M, Feig M, Nitsche A, Rieck T, Rexroth U, Eckmanns T, Hamouda O. Erratum zu: Erfassung der Labortestungen auf SARS-CoV-2 in Deutschland. . Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Oct;64(10):1315. doi: 10.1007/s00103-021-03398-7. German. PMID: 34387716; PMCID: PMC8360817.
Copy Download .nbib Format: NLM
Post-Treatment HPV Surface Brushings and Risk of Relapse in Oropharyngeal Carcinoma.

Cancers

Kofler B, Borena W, Dudas J, Innerhofer V, Dejaco D, Steinbichler TB, Widmann G, von Laer D, Riechelmann H.
PMID: 32344907
Cancers (Basel). 2020 Apr 25;12(5). doi: 10.3390/cancers12051069.

Human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC) is a distinct subtype of head and neck cancer. Here, we investigated how frequently brushing remained high-risk (hr)-HPV positive after treatment and whether patients with positive post-treatment brushings have a higher...

Cite
Kofler B, Borena W, Dudas J, et al. Post-Treatment HPV Surface Brushings and Risk of Relapse in Oropharyngeal Carcinoma. Cancers (Basel). 2020;12(5)doi: 10.3390/cancers12051069.
Kofler, B., Borena, W., Dudas, J., Innerhofer, V., Dejaco, D., Steinbichler, T. B., Widmann, G., von Laer, D., & Riechelmann, H. (2020). Post-Treatment HPV Surface Brushings and Risk of Relapse in Oropharyngeal Carcinoma. Cancers, 12(5), . https://doi.org/10.3390/cancers12051069
Kofler, Barbara, et al. "Post-Treatment HPV Surface Brushings and Risk of Relapse in Oropharyngeal Carcinoma." Cancers vol. 12,5 (2020). doi: https://doi.org/10.3390/cancers12051069
Kofler B, Borena W, Dudas J, Innerhofer V, Dejaco D, Steinbichler TB, Widmann G, von Laer D, Riechelmann H. Post-Treatment HPV Surface Brushings and Risk of Relapse in Oropharyngeal Carcinoma. Cancers (Basel). 2020 Apr 25;12(5). doi: 10.3390/cancers12051069. PMID: 32344907; PMCID: PMC7281576.
Copy Download .nbib Format: NLM
Radiocaesium sorption on natural glauconite sands is unexpectedly as strong as on Boom Clay.

The Science of the total environment

Bruneel Y, Van Laer L, Brassinnes S, Smolders E.
PMID: 32145613
Sci Total Environ. 2020 Jun 10;720:137392. doi: 10.1016/j.scitotenv.2020.137392. Epub 2020 Feb 22.

The Neogene-Paleogene glauconite sands of Belgium cover the Boom Clay deposits that are candidate host for radioactive waste disposal. It is unclear if the highly permeable sand formations may act as an additional barrier for radiocesium (

Cite
Bruneel Y, Van Laer L, Brassinnes S, et al. Radiocaesium sorption on natural glauconite sands is unexpectedly as strong as on Boom Clay. Sci Total Environ. 2020;720:137392doi: 10.1016/j.scitotenv.2020.137392.
Bruneel, Y., Van Laer, L., Brassinnes, S., & Smolders, E. (2020). Radiocaesium sorption on natural glauconite sands is unexpectedly as strong as on Boom Clay. The Science of the total environment, 720137392. https://doi.org/10.1016/j.scitotenv.2020.137392
Bruneel, Y, et al. "Radiocaesium sorption on natural glauconite sands is unexpectedly as strong as on Boom Clay." The Science of the total environment vol. 720 (2020): 137392. doi: https://doi.org/10.1016/j.scitotenv.2020.137392
Bruneel Y, Van Laer L, Brassinnes S, Smolders E. Radiocaesium sorption on natural glauconite sands is unexpectedly as strong as on Boom Clay. Sci Total Environ. 2020 Jun 10;720:137392. doi: 10.1016/j.scitotenv.2020.137392. Epub 2020 Feb 22. PMID: 32145613.
Copy Download .nbib Format: NLM
Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity.

Frontiers in oncology

Szturz P, Van Laer C, Simon C, Van Gestel D, Bourhis J, Vermorken JB.
PMID: 32435619
Front Oncol. 2020 May 06;10:688. doi: 10.3389/fonc.2020.00688. eCollection 2020.

The traditional concept of post-treatment surveillance in head and neck cancer patients relies on examinations directed at early detection of disease recurrence and/or second primary tumors. They are usually provided by ear, nose and throat specialists with complementary input...

Cite
Szturz P, Van Laer C, Simon C, et al. Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity. Front Oncol. 2020;10:688doi: 10.3389/fonc.2020.00688.
Szturz, P., Van Laer, C., Simon, C., Van Gestel, D., Bourhis, J., & Vermorken, J. B. (2020). Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity. Frontiers in oncology, 10688. https://doi.org/10.3389/fonc.2020.00688
Szturz, Petr, et al. "Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity." Frontiers in oncology vol. 10 (2020): 688. doi: https://doi.org/10.3389/fonc.2020.00688
Szturz P, Van Laer C, Simon C, Van Gestel D, Bourhis J, Vermorken JB. Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity. Front Oncol. 2020 May 06;10:688. doi: 10.3389/fonc.2020.00688. eCollection 2020. PMID: 32435619; PMCID: PMC7218054.
Copy Download .nbib Format: NLM
VariantDB: a flexible annotation and filtering portal for next generation sequencing data.

Genome medicine

Vandeweyer G, Van Laer L, Loeys B, Van den Bulcke T, Kooy RF.
PMID: 25352915
Genome Med. 2014 Oct 02;6(10):74. doi: 10.1186/s13073-014-0074-6. eCollection 2014.

Interpretation of the multitude of variants obtained from next generation sequencing (NGS) is labor intensive and complex. Web-based interfaces such as Galaxy streamline the generation of variant lists but lack flexibility in the downstream annotation and filtering that are...

Cite
Vandeweyer G, Van Laer L, Loeys B, et al. VariantDB: a flexible annotation and filtering portal for next generation sequencing data. Genome Med. 2014;6(10):74doi: 10.1186/s13073-014-0074-6.
Vandeweyer, G., Van Laer, L., Loeys, B., Van den Bulcke, T., & Kooy, R. F. (2014). VariantDB: a flexible annotation and filtering portal for next generation sequencing data. Genome medicine, 6(10), 74. https://doi.org/10.1186/s13073-014-0074-6
Vandeweyer, Geert, et al. "VariantDB: a flexible annotation and filtering portal for next generation sequencing data." Genome medicine vol. 6,10 (2014): 74. doi: https://doi.org/10.1186/s13073-014-0074-6
Vandeweyer G, Van Laer L, Loeys B, Van den Bulcke T, Kooy RF. VariantDB: a flexible annotation and filtering portal for next generation sequencing data. Genome Med. 2014 Oct 02;6(10):74. doi: 10.1186/s13073-014-0074-6. eCollection 2014. PMID: 25352915; PMCID: PMC4210545.
Copy Download .nbib Format: NLM
Correction: Arterial tortuosity syndrome: 40 new families and literature review.

Genetics in medicine : official journal of the American College of Medical Genetics

Beyens A, Albuisson J, Boel A, Al-Essa M, Al-Manea W, Bonnet D, Bostan O, Boute O, Busa T, Canham N, Cil E, Coucke PJ, Cousin MA, Dasouki M, De Backer J, De Paepe A, De Schepper S, De Silva D, Devriendt K, De Wandele I, Deyle DR, Dietz H, Dupuis-Girod S, Fontenot E, Fischer-Zirnsak B, Gezdirici A, Ghoumid J, Giuliano F, Baena N, Haider MZ, Hardin JS, Jeunemaitre X, Klee EW, Kornak U, Landecho MF, Legrand A, Loeys B, Lyonnet S, Michael H, Moceri P, Mohammed S, Muiño-Mosquera L, Nampoothiri S, Pichler K, Prescott K, Rajeb A, Ramos-Arroyo M, Rossi M, Salih M, Seidahmed MZ, Schaefer E, Steichen-Gersdorf E, Temel S, Uysal F, Vanhomwegen M, Van Laer L, Van Maldergem L, Warner D, Willaert A, Collins Ii TR, Taylor A, Davis EC, Zarate Y, Callewaert B.
PMID: 30201961
Genet Med. 2019 Aug;21(8):1894-1895. doi: 10.1038/s41436-018-0035-3.

In the published version of this paper the author Neus Baena's name was incorrectly given as Neus Baena Diez. This has now been corrected in both the HTML and PDF versions of the paper.

Cite
Beyens A, Albuisson J, Boel A, et al. Correction: Arterial tortuosity syndrome: 40 new families and literature review. Genet Med. 2019;21(8):1894-1895doi: 10.1038/s41436-018-0035-3.
Beyens, A., Albuisson, J., Boel, A., Al-Essa, M., Al-Manea, W., Bonnet, D., Bostan, O., Boute, O., Busa, T., Canham, N., Cil, E., Coucke, P. J., Cousin, M. A., Dasouki, M., De Backer, J., De Paepe, A., De Schepper, S., De Silva, D., Devriendt, K., De Wandele, I., Deyle, D. R., Dietz, H., Dupuis-Girod, S., Fontenot, E., Fischer-Zirnsak, B., Gezdirici, A., Ghoumid, J., Giuliano, F., Baena, N., Haider, M. Z., Hardin, J. S., Jeunemaitre, X., Klee, E. W., Kornak, U., Landecho, M. F., Legrand, A., Loeys, B., Lyonnet, S., Michael, H., Moceri, P., Mohammed, S., Muiño-Mosquera, L., Nampoothiri, S., Pichler, K., Prescott, K., Rajeb, A., Ramos-Arroyo, M., Rossi, M., Salih, M., Seidahmed, M. Z., Schaefer, E., Steichen-Gersdorf, E., Temel, S., Uysal, F., Vanhomwegen, M., Van Laer, L., Van Maldergem, L., Warner, D., Willaert, A., Collins Ii, T. R., Taylor, A., Davis, E. C., Zarate, Y., & Callewaert, B. (2019). Correction: Arterial tortuosity syndrome: 40 new families and literature review. Genetics in medicine : official journal of the American College of Medical Genetics, 21(8), 1894-1895. https://doi.org/10.1038/s41436-018-0035-3
Beyens, Aude, et al. "Correction: Arterial tortuosity syndrome: 40 new families and literature review." Genetics in medicine : official journal of the American College of Medical Genetics vol. 21,8 (2019): 1894-1895. doi: https://doi.org/10.1038/s41436-018-0035-3
Beyens A, Albuisson J, Boel A, Al-Essa M, Al-Manea W, Bonnet D, Bostan O, Boute O, Busa T, Canham N, Cil E, Coucke PJ, Cousin MA, Dasouki M, De Backer J, De Paepe A, De Schepper S, De Silva D, Devriendt K, De Wandele I, Deyle DR, Dietz H, Dupuis-Girod S, Fontenot E, Fischer-Zirnsak B, Gezdirici A, Ghoumid J, Giuliano F, Baena N, Haider MZ, Hardin JS, Jeunemaitre X, Klee EW, Kornak U, Landecho MF, Legrand A, Loeys B, Lyonnet S, Michael H, Moceri P, Mohammed S, Muiño-Mosquera L, Nampoothiri S, Pichler K, Prescott K, Rajeb A, Ramos-Arroyo M, Rossi M, Salih M, Seidahmed MZ, Schaefer E, Steichen-Gersdorf E, Temel S, Uysal F, Vanhomwegen M, Van Laer L, Van Maldergem L, Warner D, Willaert A, Collins Ii TR, Taylor A, Davis EC, Zarate Y, Callewaert B. Correction: Arterial tortuosity syndrome: 40 new families and literature review. Genet Med. 2019 Aug;21(8):1894-1895. doi: 10.1038/s41436-018-0035-3. PMID: 30201961.
Copy Download .nbib Format: NLM
Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome.

Annals of cardiothoracic surgery

Meester JAN, Verstraeten A, Schepers D, Alaerts M, Van Laer L, Loeys BL.
PMID: 29270370
Ann Cardiothorac Surg. 2017 Nov;6(6):582-594. doi: 10.21037/acs.2017.11.03.

Many different heritable connective tissue disorders (HCTD) have been described over the past decades. These syndromes often affect the connective tissue of various organ systems, including heart, blood vessels, skin, joints, bone, eyes, and lungs. The discovery of these...

Cite
Meester JAN, Verstraeten A, Schepers D, et al. Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome. Ann Cardiothorac Surg. 2017;6(6):582-594doi: 10.21037/acs.2017.11.03.
Meester, J. A. N., Verstraeten, A., Schepers, D., Alaerts, M., Van Laer, L., & Loeys, B. L. (2017). Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome. Annals of cardiothoracic surgery, 6(6), 582-594. https://doi.org/10.21037/acs.2017.11.03
Meester, Josephina A N, et al. "Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome." Annals of cardiothoracic surgery vol. 6,6 (2017): 582-594. doi: https://doi.org/10.21037/acs.2017.11.03
Meester JAN, Verstraeten A, Schepers D, Alaerts M, Van Laer L, Loeys BL. Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome. Ann Cardiothorac Surg. 2017 Nov;6(6):582-594. doi: 10.21037/acs.2017.11.03. PMID: 29270370; PMCID: PMC5721110.
Copy Download .nbib Format: NLM
Candidate Gene Resequencing in a Large Bicuspid Aortic Valve-Associated Thoracic Aortic Aneurysm Cohort: .

Frontiers in physiology

Gillis E, Kumar AA, Luyckx I, Preuss C, Cannaerts E, van de Beek G, Wieschendorf B, Alaerts M, Bolar N, Vandeweyer G, Meester J, Wünnemann F, Gould RA, Zhurayev R, Zerbino D, Mohamed SA, Mital S, Mertens L, Björck HM, Franco-Cereceda A, McCallion AS, Van Laer L, Verhagen JMA, van de Laar IMBH, Wessels MW, Messas E, Goudot G, Nemcikova M, Krebsova A, Kempers M, Salemink S, Duijnhouwer T, Jeunemaitre X, Albuisson J, Eriksson P, Andelfinger G, Dietz HC, Verstraeten A, Loeys BL.
PMID: 28659821
Front Physiol. 2017 Jun 13;8:400. doi: 10.3389/fphys.2017.00400. eCollection 2017.

Bicuspid aortic valve (BAV) is the most common congenital heart defect. Although many BAV patients remain asymptomatic, at least 20% develop thoracic aortic aneurysm (TAA). Historically, BAV-related TAA was considered as a hemodynamic consequence of the valve defect. Multiple...

Cite
Gillis E, Kumar AA, Luyckx I, et al. Candidate Gene Resequencing in a Large Bicuspid Aortic Valve-Associated Thoracic Aortic Aneurysm Cohort: . Front Physiol. 2017;8:400doi: 10.3389/fphys.2017.00400.
Gillis, E., Kumar, A. A., Luyckx, I., Preuss, C., Cannaerts, E., van de Beek, G., Wieschendorf, B., Alaerts, M., Bolar, N., Vandeweyer, G., Meester, J., Wünnemann, F., Gould, R. A., Zhurayev, R., Zerbino, D., Mohamed, S. A., Mital, S., Mertens, L., Björck, H. M., Franco-Cereceda, A., McCallion, A. S., Van Laer, L., Verhagen, J. M. A., van de Laar, I. M. B. H., Wessels, M. W., Messas, E., Goudot, G., Nemcikova, M., Krebsova, A., Kempers, M., Salemink, S., Duijnhouwer, T., Jeunemaitre, X., Albuisson, J., Eriksson, P., Andelfinger, G., Dietz, H. C., Verstraeten, A., Loeys, B. L. (2017). Candidate Gene Resequencing in a Large Bicuspid Aortic Valve-Associated Thoracic Aortic Aneurysm Cohort: . Frontiers in physiology, 8400. https://doi.org/10.3389/fphys.2017.00400
Gillis, Elisabeth, et al. "Candidate Gene Resequencing in a Large Bicuspid Aortic Valve-Associated Thoracic Aortic Aneurysm Cohort: ." Frontiers in physiology vol. 8 (2017): 400. doi: https://doi.org/10.3389/fphys.2017.00400
Gillis E, Kumar AA, Luyckx I, Preuss C, Cannaerts E, van de Beek G, Wieschendorf B, Alaerts M, Bolar N, Vandeweyer G, Meester J, Wünnemann F, Gould RA, Zhurayev R, Zerbino D, Mohamed SA, Mital S, Mertens L, Björck HM, Franco-Cereceda A, McCallion AS, Van Laer L, Verhagen JMA, van de Laar IMBH, Wessels MW, Messas E, Goudot G, Nemcikova M, Krebsova A, Kempers M, Salemink S, Duijnhouwer T, Jeunemaitre X, Albuisson J, Eriksson P, Andelfinger G, Dietz HC, Verstraeten A, Loeys BL. Candidate Gene Resequencing in a Large Bicuspid Aortic Valve-Associated Thoracic Aortic Aneurysm Cohort: . Front Physiol. 2017 Jun 13;8:400. doi: 10.3389/fphys.2017.00400. eCollection 2017. PMID: 28659821; PMCID: PMC5469151.
Copy Download .nbib Format: NLM
Resolving the energy levels of a nanomechanical oscillator.

Nature

Arrangoiz-Arriola P, Wollack EA, Wang Z, Pechal M, Jiang W, McKenna TP, Witmer JD, Van Laer R, Safavi-Naeini AH.
PMID: 31341303
Nature. 2019 Jul;571(7766):537-540. doi: 10.1038/s41586-019-1386-x. Epub 2019 Jul 24.

The quantum nature of an oscillating mechanical object is anything but apparent. The coherent states that describe the classical motion of a mechanical oscillator do not have a well defined energy, but are quantum superpositions of equally spaced energy...

Cite
Arrangoiz-Arriola P, Wollack EA, Wang Z, et al. Resolving the energy levels of a nanomechanical oscillator. Nature. 2019;571(7766):537-540doi: 10.1038/s41586-019-1386-x.
Arrangoiz-Arriola, P., Wollack, E. A., Wang, Z., Pechal, M., Jiang, W., McKenna, T. P., Witmer, J. D., Van Laer, R., & Safavi-Naeini, A. H. (2019). Resolving the energy levels of a nanomechanical oscillator. Nature, 571(7766), 537-540. https://doi.org/10.1038/s41586-019-1386-x
Arrangoiz-Arriola, Patricio, et al. "Resolving the energy levels of a nanomechanical oscillator." Nature vol. 571,7766 (2019): 537-540. doi: https://doi.org/10.1038/s41586-019-1386-x
Arrangoiz-Arriola P, Wollack EA, Wang Z, Pechal M, Jiang W, McKenna TP, Witmer JD, Van Laer R, Safavi-Naeini AH. Resolving the energy levels of a nanomechanical oscillator. Nature. 2019 Jul;571(7766):537-540. doi: 10.1038/s41586-019-1386-x. Epub 2019 Jul 24. PMID: 31341303.
Copy Download .nbib Format: NLM
Cryogenic packaging of an optomechanical crystal.

Optics express

McKenna TP, Patel RN, Witmer JD, Van Laer R, Valery JA, Safavi-Naeini AH.
PMID: 31684622
Opt Express. 2019 Sep 30;27(20):28782-28791. doi: 10.1364/OE.27.028782.

There is an increasing need to simplify optical coupling techniques for low-temperature integrated photonics experiments. Various promising and scalable photonic packaging techniques have been under development, but few methods compatible with low-temperature operation have been reported. Here, we demonstrate...

Cite
McKenna TP, Patel RN, Witmer JD, et al. Cryogenic packaging of an optomechanical crystal. Opt Express. 2019;27(20):28782-28791doi: 10.1364/OE.27.028782.
McKenna, T. P., Patel, R. N., Witmer, J. D., Van Laer, R., Valery, J. A., & Safavi-Naeini, A. H. (2019). Cryogenic packaging of an optomechanical crystal. Optics express, 27(20), 28782-28791. https://doi.org/10.1364/OE.27.028782
McKenna, Timothy P, et al. "Cryogenic packaging of an optomechanical crystal." Optics express vol. 27,20 (2019): 28782-28791. doi: https://doi.org/10.1364/OE.27.028782
McKenna TP, Patel RN, Witmer JD, Van Laer R, Valery JA, Safavi-Naeini AH. Cryogenic packaging of an optomechanical crystal. Opt Express. 2019 Sep 30;27(20):28782-28791. doi: 10.1364/OE.27.028782. PMID: 31684622.
Copy Download .nbib Format: NLM
Stroke in patients with cancer in the era of hyper-acute stroke intervention.

Internal medicine journal

Davies A, Van Leer L, Chan J, Wijayaratna R, Singhal S, Ly J, Clissold B, Ma H, Phan TG.
PMID: 33974349
Intern Med J. 2021 May 11; doi: 10.1111/imj.15353. Epub 2021 May 11.

OBJECTIVE: The natural history of patients with stroke and cancer remains poorly understood in the modern era of hyper-acute stroke therapies (recombinant tissue plasminogen activator (tPA) and endovascular clot retrieval (ECR)). Prior to these advances in stroke treatment, a...

Cite
Davies A, Van Leer L, Chan J, et al. Stroke in patients with cancer in the era of hyper-acute stroke intervention. Intern Med J. 2021;doi: 10.1111/imj.15353.
Davies, A., Van Leer, L., Chan, J., Wijayaratna, R., Singhal, S., Ly, J., Clissold, B., Ma, H., & Phan, T. G. (2021). Stroke in patients with cancer in the era of hyper-acute stroke intervention. Internal medicine journal, . https://doi.org/10.1111/imj.15353
Davies, Amy, et al. "Stroke in patients with cancer in the era of hyper-acute stroke intervention." Internal medicine journal vol. (2021). doi: https://doi.org/10.1111/imj.15353
Davies A, Van Leer L, Chan J, Wijayaratna R, Singhal S, Ly J, Clissold B, Ma H, Phan TG. Stroke in patients with cancer in the era of hyper-acute stroke intervention. Intern Med J. 2021 May 11; doi: 10.1111/imj.15353. Epub 2021 May 11. PMID: 33974349.
Copy Download .nbib Format: NLM
Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect.

Cancers

Hofer T, Rossi M, Carboni S, Di Berardino Besson W, von Laer D, Wollmann G, Derouazi M, Santiago-Raber ML.
PMID: 34885215
Cancers (Basel). 2021 Dec 03;13(23). doi: 10.3390/cancers13236107.

Heterologous prime-boost settings with a protein vaccine and the viral vector vesicular stomatitis virus, both expressing tumor-associated antigens (KISIMA-TAA and VSV-GP-TAA), have been previously shown to generate potent antitumor immunity. In the cold TC-1 model (HPV antigen) and the...

Cite
Hofer T, Rossi M, Carboni S, et al. Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect. Cancers (Basel). 2021;13(23)doi: 10.3390/cancers13236107.
Hofer, T., Rossi, M., Carboni, S., Di Berardino Besson, W., von Laer, D., Wollmann, G., Derouazi, M., & Santiago-Raber, M. L. (2021). Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect. Cancers, 13(23), . https://doi.org/10.3390/cancers13236107
Hofer, Tamara, et al. "Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect." Cancers vol. 13,23 (2021). doi: https://doi.org/10.3390/cancers13236107
Hofer T, Rossi M, Carboni S, Di Berardino Besson W, von Laer D, Wollmann G, Derouazi M, Santiago-Raber ML. Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect. Cancers (Basel). 2021 Dec 03;13(23). doi: 10.3390/cancers13236107. PMID: 34885215; PMCID: PMC8656755.
Copy Download .nbib Format: NLM
Showing 73 to 84 of 84 entries